secwatch.observer — SEC 8-K summary
======================================

Issuer:     ULTRALIFE CORP (ULBI)
CIK:        0000875657
Form:       8-K
Filed at:   2024-11-08T23:59:59+00:00
Accession:  0001437749-24-034046
Event type: earnings
Sentiment:  negative
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ultralife Q3 EPS $0.02 vs $0.08; revenue $35.7M (-9.6%); backlog $78M
---------------------------------------------------------------------

- GAAP diluted EPS $0.02, down from $0.08; net income $0.3M vs $1.3M Q3 2023.
- Revenue $35.7M, down 9.6% YoY; Battery & Energy +1.9%, Communications Systems -58.2%.
- Backlog $78.0M; debt reduced 33.4% to $8.0M from $12.1M at Q2 end.
- Acquisition of Electrochem Solutions completed Oct 31; related costs $0.3M in Q3.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/875657/000143774924034046/0001437749-24-034046-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/875657/000143774924034046/ulbi20241107_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-034046

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer